ESC Premium Access

The platelet protease-activated receptor-4 antagonist, UDM-002555, alone and in combination with aspirin inhibits arterial thrombosis with limited impact on hemostasis in cynomolgus monkeys

Congress Presentation

About the speaker

Doctor Pancras Wong

Bristol Myers Squibb, Princeton (United States of America)
0 follower

6 more presentations in this session

Platelet responsiveness to PAR4 activation in a healthy population and its inhibition by a potent and selective PAR4 antagonist

Speaker: Doctor K. Downes (Cambridge, GB)

Thumbnail

Can off-pump coronary artery bypass graft surgery be performed 3 days after clopidogrel discontinuation without increasing the bleeding risk in acute coronary syndrome patients?

Speaker: Mr W. Liu (Beijing, CN)

Thumbnail

Evaluation of immature platelet parameters as compared to established predictors of platelet reactivity after thienopyridine loading

Speaker: Doctor C. Stratz (Bad Krozingen, DE)

Thumbnail

Impact of diabetes mellitus on the pharmacodynamic effects of ticagrelor versus clopidogrel in troponin-negative acute coronary syndrome patients undergoing ad-hoc percutaneous coronary intervention

Speaker: Professor J. Sweeny (New York City, US)

Thumbnail

Large mean platelet volume is associated with impaired clopidogrel-responsiveness in acute coronary syndrome patients, with no impact on prasugrel or ticagrelor effects

Speaker: Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)

Thumbnail

Access the full session

Mechanisms of platelet activation

Speakers: Doctor P. Wong, Doctor K. Downes, Mr W. Liu, Doctor C. Stratz, Professor J. Sweeny...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by